Ginkgo Bioworks Holdings Cash Flow Statement (2020-2026) | DNA

Cash Flow Statement Sep2020 Dec2020 Mar2021 Jun2021 Sep2021 Dec2021 Mar2022 Jun2022 Sep2022 Dec2022 Mar2023 Jun2023 Sep2023 Dec2023 Mar2024 Jun2024 Sep2024 Dec2024 Mar2025 Jun2025 Sep2025 Dec2025 Mar2026
Operating Activities
Net Income (Quarter)
-54.46M-102.41M-1604.99M-592.59M-670.57M-670.13M-173.08M-204.97M-173.31M-302.89M-211.69M-165.91M-217.18M-56.40M-107.53M-7.65M-60.30M-80.75M-80.75M-6.53M
Share-based Compensation (Quarter)
14.52M0.13M1,591.26M652.82M606.51M563.38M108.17M72.99M62.48M53.65M-187.02M40.78M38.23M14.01M-91.78M17.39M22.53M18.10M21.03M15.85M
Cash from Discontinued Operations (Quarter)
-8.77M-0.25M
Gains from Investment Securities (Quarter)
18.48M-77.10M-85.03M-23.51M12.45M-28.87M-1.20M4.48M-1.89M-6.55M-0.94M-3.23M-1.53M
Asset Writedowns and Impairment (Quarter)
9.00M112.40M121.40M47.86M
Change in Working Capital (Quarter)
2.65M2.68M8.52M4.73M
Change in Receivables (Quarter)
86.26M-34.50M0.53M-15.92M-5.77M-28.90M6.77M-5.67M5.00M-1.38M0.67M-0.26M-0.76M1.82M0.24M
Change in Inventory (Quarter)
-0.70M0.76M-0.11M5.33M-0.59M-2.24M-2.66M-1.85M-0.69M
Change in Account Payables (Quarter)
-7.84M4.55M0.52M26.25M-15.60M-6.76M-14.74M9.68M-6.69M
Change in Accured Expenses (Quarter)
2.33M10.46M15.20M9.97M-22.85M1.03M-27.79M19.08M-23.08M-0.82M21.72M10.87M-0.01M-41.96M-9.34M8.87M-13.99M22.12M-6.62M-11.60M
Other Working Capital Changes (Quarter)
-3.22M-0.71M9.17M-0.13M-4.25M-0.86M13.75M-7.44M-4.64M-1.47M3.08M-1.15M-0.62M-1.72M-6.60M0.58M1.69M-2.20M5.18M-5.93M
Cash from Operations (Quarter)
-34.91M-5.24M-165.54M-19.90M-99.41M-28.36M-104.53M-90.58M-73.53M-73.55M-57.83M-89.26M-84.39M-103.50M-42.44M-42.75M-49.03M-31.61M-47.68M-46.43M
Depreciation, Depletion & Amortization
Amortization of Goodwill (Quarter)
47.90M
Amortization of Deferred Charges (Quarter)
7.21M8.04M8.29M8.31M3.68M5.64M7.43M7.55M7.48M7.38M7.49M7.58M7.63M7.11M
Depreciation & Amortization (CF) (Quarter)
6.94M8.15M8.00M8.94M9.03M8.92M15.67M18.96M17.65M21.06M12.84M12.87M17.33M17.17M15.65M14.82M15.79M14.17M13.66M12.80M
Investing Activities
Capital Expenditures (Quarter)
24.03M5.44M-50.87M-2.21M2.63M9.58M42.27M19.44M13.53M-30.24M38.07M6.71M-5.88M-0.64M62.34M7.62M-7.50M7.54M0.01M-0.09M
Sales of Property, Plant and Equipment (Quarter)
0.06M-0.06M0.11M-0.11M0.62M2.31M0.07M1.43M0.40M0.06M0.57M
Acquisitions (Quarter)
-1.21M21.38M-9.34M5.40M
Change in Acquisitions & Divestments (Quarter)
0.10M0.06M-0.03M4.52M64.96M-64.96M25.90M108.18M
Cash from Investing Activities (Quarter)
-23.93M-30.51M4.23M-35.98M-14.66M-46.49M29.74M-19.41M-11.22M-3.38M-46.67M-12.11M-26.84M-10.20M-13.09M-198.68M-63.89M-72.82M95.10M23.13M
Financing Activities
Other financing activities (Quarter)
0.01M0.00M0.13M0.07M-0.98M-0.09M100.30M0.01M-0.61M-0.00M1.18M0.07M0.01M-0.08M
Cash from Financing Activities (Quarter)
-2.12M1,547.74M-11.04M-1.19M-0.84M-0.39M97.76M-0.89M-1.38M-0.32M-0.63M-0.84M-0.23M-0.47M-0.20M-0.21M-0.10M9.94M8.14M-0.02M
Change in Capital Stock
Net Equity Issued and Repurchased (Quarter)
15.09M-15.09M7.59M-24.61M9.15M
Additional items
Exchange Rate Effect (Quarter)
-0.88M-0.01M-0.01M-0.10M-0.09M1.10M-0.03M-0.47M-0.20M0.10M-0.16M-0.02M-0.04M-0.07M0.07M0.19M0.09M-0.15M-0.13M
Change in Cash (Quarter)
-60.97M1,511.99M-172.37M-57.08M-115.01M-75.33M24.07M-110.91M-86.61M-77.44M-105.03M-102.37M-111.47M-114.20M-55.80M-250.34M-104.05M-94.39M55.41M-23.70M
Free Cash Flow (Quarter)
-58.95M-10.67M-114.67M-17.69M-102.04M-37.94M-146.80M-110.03M-87.07M-43.31M-95.90M-95.97M-78.51M-102.86M-104.78M-50.37M-41.53M-39.14M-47.68M-46.34M
Net Cash Flow (Quarter)
-60.97M1,512.00M-172.36M-57.08M-114.91M-75.24M22.97M-110.89M-86.14M-77.25M-105.14M-102.21M-111.46M-114.17M-55.72M-241.64M-113.01M-94.48M55.56M-23.32M